|Bid||93.13 x 1100|
|Ask||93.50 x 900|
|Day's Range||86.50 - 93.20|
|52 Week Range||3.54 - 189.40|
|Beta (5Y Monthly)||1.39|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 10, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||227.60|
Dr. Kanika Monga, Rheumatologist in Houston, Texas, joins Yahoo Finance’s Akiko Fujita to break down the latest coronavirus developments, as cases across the U.S. continue to spike.
As we (hopefully) approach the finish line in the COVID-19 vaccine race, it's a wonderful time to buy shares of Novavax and Sanofi.
These clinical stage biotech players have won billions in funding -- and the attention of investors.